Surveillance of antimicrobials use in Emergency Medicine Institute
Închide
Conţinutul numărului revistei
Articolul precedent
Articolul urmator
931 4
Ultima descărcare din IBN:
2018-09-06 21:50
Căutarea după subiecte
similare conform CZU
616-022.7-085:615.33:614.253.1 (1)
Patologie. Medicină clinică (6850)
Medicamentele potrivit originii lor (470)
Organizarea publică şi profesională a sănătăţii (860)
SM ISO690:2012
BERNAZ, Emelian, CIOBANU, Gheorghe, TENTIUC, Elizaveta, BOROVIC, Eduard, VOVC, Liviu. Surveillance of antimicrobials use in Emergency Medicine Institute. In: Moldovan Medical Journal, 2017, nr. 1(60), pp. 39-43. ISSN 2537-6373.
EXPORT metadate:
Google Scholar
Crossref
CERIF

DataCite
Dublin Core
Moldovan Medical Journal
Numărul 1(60) / 2017 / ISSN 2537-6373 /ISSNe 2537-6381

Surveillance of antimicrobials use in Emergency Medicine Institute
CZU: 616-022.7-085:615.33:614.253.1

Pag. 39-43

Bernaz Emelian1, Ciobanu Gheorghe1, Tentiuc Elizaveta2, Borovic Eduard3, Vovc Liviu3
 
1 ”Nicolae Testemițanu” State University of Medicine and Pharmacy,
2 Agency of Medicine and Medical Devices,
3 Emergency Institute of Medicine
 
Disponibil în IBN: 3 martie 2017


Rezumat

Background: Antibiotics have had a profound impact on humanity’s health, by improving our ability to prevent, cure and reduce the transmission of many infectious diseases. It is widely known, that the unnecessary or inappropriate use of antibiotics, occurs up to 50% of prescriptions only in the United States and Canada. Fortunately all negative impact on the human health can be roughly imagined. Material and methods: For this study we used the data of a six-year (2009-2014) period in the Emergency Medicine Institute and their main subdivisions which show the consumption dynamics of antibacterials use in natural indexes. Results: The total annual medium consumption of antimicrobials was registered as the following: ICD 1796.98 DDD/1000, SSOTD 566.12 DDD/1000 and EMI 584.05DDD/1000, with the parenteral to enteral forms share of respectively 94.67% to 5.33%, 85.62% to 14.38% and 83.52% to 16.48%. Five from nine main groups: beta-lactam antibacterials, penicilins, other beta-lactam, aminoglycoside, other antibacterials and quinolone antibacterials registered around 90% of all antibiotics consumption. Comparatively to Australian hospitals and hospitals other worldwide countries in EMI consumption per DDD/1000 was lower: by 3.39 and 2.22 times for tetracyclines, by 5.1 and 4.63 for beta-lactam and penicilins, as well as by 2.55 and 1.63 for macrolides and lincosamides. Conclusions: The obtained data about the dynamics of antibacterials consumption in EMI and their main departments, in comparison with hospitals from other worldwide countries, represents important arguments and reserves for improving quality treatment, planning, rational prescription and utilization of antibiotics in hospitals.

Cuvinte-cheie
antibacterials, defined daily dose, consumption, hospitals, utilization, occupied-bed days